| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 02/14/2002 | CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | CA2417358A1 Bio-intermediates for use in the chemical synthesis of polyketides |
| 02/13/2002 | EP1179532A1 Process for the production of indole derivatives and intermediates therefor |
| 02/13/2002 | EP1179527A1 Cyanobiphenyl derivatives |
| 02/13/2002 | EP1179345A1 Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives |
| 02/13/2002 | EP1179344A1 Release-regulating preparations |
| 02/13/2002 | EP1179341A1 Remedies or preventives for diseases in association with chemokines |
| 02/13/2002 | EP1178984A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/13/2002 | EP1178962A1 Process for the preparation of paroxetine acetate and analogues thereof |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP1178800A1 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 02/13/2002 | EP1178784A1 New pharmaceutical combinations for nos inhibitors |
| 02/13/2002 | EP0727997B1 Pharmaceutical emulsion |
| 02/13/2002 | CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use |
| 02/13/2002 | CN1335835A Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5HT1A receptor activity |
| 02/13/2002 | CN1335771A N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/12/2002 | US6346547 N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith |
| 02/12/2002 | US6346540 1-(1,2-disubstituted pipeidinyl)-4-substituted piperidine derivatives |
| 02/12/2002 | CA2094702C Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 02/12/2002 | CA2067877C Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present |
| 02/12/2002 | CA2024399C Compounds |
| 02/07/2002 | WO2002010177A1 Ammonium salts of inositol hexaphosphate and uses thereof |
| 02/07/2002 | WO2002010162A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010115A1 New processes for the production of fexofenadine |
| 02/07/2002 | WO2002009707A1 Fentanyl composition for nasal administration |
| 02/07/2002 | WO2002009694A1 Anticonvulsant derivatives useful for the treatment of depression |
| 02/07/2002 | WO2002009686A2 Cdc25 phosphatase inhibitors |
| 02/07/2002 | WO2001085098A3 Squarate derivatives of dihydropyridine npy antagonists |
| 02/07/2002 | WO2001081310A8 1-aroyl-piperidinyl benzamidines |
| 02/07/2002 | WO2001070688A3 N-(2,6-dioxo-piperidin-3-yl) benzamides and their use as immune modulators |
| 02/07/2002 | US20020016467 Novel 4-diphenylmethyl piperdine derivatives |
| 02/07/2002 | US20020016466 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor |
| 02/07/2002 | US20020016465 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
| 02/07/2002 | US20020016464 Sodium channel blockers used to treat amyotrophic lateral sclerosis; analgesics, anticonvulsants, antidepressants, local anesthetics and antiarrhythmics |
| 02/07/2002 | US20020016462 Producing 3-amino-1-benzylpyrrolidine and 8-benzyl-2,8-diaza bicyclo(4.3.0)-nonane; reaction mixture added to an aqueous solution in which substances containging alpha-hydroxy carboxyl and/or alpha-aminocarboxyl groups are dissolved |
| 02/07/2002 | US20020016448 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines |
| 02/07/2002 | US20020016447 The ketoaldonic acid methyl ester is converted into the oxime which is then reduced to the amine which cyclizes to give the lactam which is then reduced to the imino sugar by borane or a metal hydride |
| 02/07/2002 | US20020016344 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 02/07/2002 | US20020016339 Anticoagulants |
| 02/07/2002 | US20020016337 Heterocyclic analgesic compounds and methods of use thereof |
| 02/07/2002 | US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use |
| 02/07/2002 | US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production. |
| 02/07/2002 | DE10037146A1 Acetamidderivate Acetamide derivatives |
| 02/07/2002 | DE10036121A1 N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate N-substituted-1-amino-1,1-dialkyl-carboxylic acid derivatives |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | CA2417304A1 Anticonvulsant derivatives useful for the treatment of depression |
| 02/07/2002 | CA2417262A1 Cdc25 phosphatase inhibitors |
| 02/07/2002 | CA2417254A1 N-¢5-¢¢¢5-alkyl-2-oxazolyl!methyl!thio!-2-thiazolyl! carboxamide inhibitors of cyclin dependent kinases |
| 02/06/2002 | EP1178041A1 Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives |
| 02/06/2002 | EP1178040A1 Nickel catalyzed addition of -NH- containing compounds to vinyl and aryl halides |
| 02/06/2002 | EP1177174A1 Hydroxamic and carboxylic acid derivatives |
| 02/06/2002 | EP1177173A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/06/2002 | EP0882024B1 Retroviral protease inhibiting compounds |
| 02/06/2002 | EP0783490B1 1-acyl-4-aliphatic aminopiperidine compounds |
| 02/06/2002 | CN1334798A Phenylglycine derivatives |
| 02/06/2002 | CN1334797A 3,4-diamino-3-cyclobutene-1,2-dione derivs. which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 02/06/2002 | CN1078889C Non-pepitde tachykinin receptor antagonists |
| 02/05/2002 | US6344561 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/05/2002 | US6344560 Nitroaromatic solubilizer for nitroxyls in aromatic solvents |
| 02/05/2002 | US6344486 Anticoagulants |
| 02/05/2002 | US6344466 Antithrombotic activity, use in inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, anticoagulants |
| 02/05/2002 | US6344464 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/05/2002 | US6344358 Administering somatostatin releasing agent to treat brain, psychological and nervous system disorders such as schizophrenia, amnesia, bipolar disorder, alzheimer*s disease and parkinson*s disease |
| 02/05/2002 | US6344213 Compounds and compositions for delivering active agents |
| 02/01/2002 | CA2354275A1 Process for preparing basic organic nitrogen-containing compounds by reduction with lithium aluminum hydride |
| 01/31/2002 | WO2001040184B1 Methods for the syntheses of alfentanil, sufentanil and remifentanil |
| 01/31/2002 | WO2001014328A3 Substituted ureas as cell adhesion inhibitors |
| 01/31/2002 | US20020013352 Novel substituted diamine derivatives useful as motilin antagonists |
| 01/31/2002 | US20020013351 Compounds possessing neuronal activity |
| 01/31/2002 | US20020013341 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, Bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition |
| 01/31/2002 | US20020013323 Oxadiazole and thiadiazole derivatives of dihydropyridine NPY antagonists |
| 01/31/2002 | US20020013321 Used as ligands for opioid receptors, for therapy of neurological and gastrointestinal disorders |
| 01/31/2002 | US20020013256 Novel inhibitors of formation of advanced glycation endproducts (AGES) |
| 01/31/2002 | DE10035144A1 Cyclische Aminosäurederivate Cyclic amino acid derivatives |
| 01/30/2002 | EP1175402A1 Piperidine derivatives useful as ccr5 antagonists |
| 01/30/2002 | EP1175401A1 Piperazine derivatives useful as ccr5 antagonists |
| 01/30/2002 | EP1175400A1 Renin inhibitors |
| 01/30/2002 | EP1175383A1 Glucocorticoid receptor modulators |
| 01/30/2002 | EP1175215A2 Use of osanetant in the production of medicaments used to treat mood disorders |
| 01/30/2002 | CN1333769A Thiourea inhibitors of herps viruses |
| 01/30/2002 | CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 01/29/2002 | US6342607 Intermediates for preparation of neurokinin antagonists |
| 01/29/2002 | US6342512 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals |
| 01/29/2002 | US6342509 Antiasthmatics, antihistamines or bronchodialators |
| 01/29/2002 | US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/29/2002 | US6342505 Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-β1 |
| 01/29/2002 | US6342504 Peptides as antithrombins and anticoagulants |
| 01/29/2002 | CA2089880C Process for producing azacycloalkane derivatives |
| 01/24/2002 | WO2002006274A1 N-(4-sulfonylaryl)cyclylamine-2-hydroxyethylamines as beta-3 adrenergic receptor agonists |
| 01/24/2002 | WO2002006255A2 Hydroxy-(piperidin-4-yl-methylamino)-alkyl beta-3 adrenergic receptor antagonists |
| 01/24/2002 | WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/24/2002 | WO2002006234A1 Sulfone derivatives, process for their production and use thereof |
| 01/24/2002 | WO2002006232A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 01/24/2002 | WO2002006231A1 Serotonin reuptake inhibitors |
| 01/24/2002 | WO2002006230A2 Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists |